Strategic Partnerships Little Journey’s established work with NHS England and its recent engagement in clinical trial support platforms suggests a strong fit for health systems seeking scalable patient journeys. This presents an opportunity to propose broader hospital and national program collaborations, leveraging their trial flow and patient prep capabilities to unify patient engagement across sites.

Clinical Trial Expansion With Trial Flow designed to standardize patient support across trials, there is potential to upsell to pharmaceutical and CROs aiming to improve adherence, retention, and protocol conformity in multi-country studies. Targeting life sciences customers with regulated, scalable patient-centric solutions could drive larger contract values.

Digital Patient Experience Little Journey focuses on reducing anxiety and improving understanding for patients and caregivers. Sales conversations can emphasize ROI in staff efficiency and reduced disruptions, positioning the platform as a core component of value-based care initiatives in hospitals and health systems.

Co-designed Innovation Their co-design and behavioural science approach can be marketed to health systems prioritizing patient-centric design and evidence-based improvement. Opportunities exist to collaborate on pilot programs within hospitals seeking to modernize patient education and preparation workflows.

Funding and Growth Signals Strong funding history and recent awards signal credibility and momentum. Use this to approach strategic buyers and venture-backed healthcare networks, offering scalable deployment and potential for joint marketing, co-branding, or expansion into new regions and languages.